Avenue Therapeutics Cash from Financing (TTM) Analysis

Avenue Therapeutics Inc (ATXI)

3.815 +0.18 (+5.10%) USD | NASDAQ | May 17, 16:00

3.88 +0.06 (+1.70%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
March 31, 2024	8.956M
December 31, 2023	7.526M
September 30, 2023	14.24M
June 30, 2023	13.64M
March 31, 2023	13.64M
December 31, 2022	10.54M
September 30, 2022	4.262M
June 30, 2022	4.381M
March 31, 2022
December 31, 2021
September 30, 2021
June 30, 2021
March 31, 2021
December 31, 2020
September 30, 2020

Date	Value
June 30, 2020
March 31, 2020
December 31, 2019	32.33M
September 30, 2019	31.44M
June 30, 2019	31.44M
March 31, 2019	31.45M
December 31, 2018	-0.895M
September 30, 2018	0.00
June 30, 2018	-6.754M
March 31, 2018	28.55M
December 31, 2017	28.39M
September 30, 2017	28.63M
June 30, 2017	35.82M
March 31, 2017	0.777M
December 31, 2016	1.815M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

4.262M

Minimum

Sep 2022

32.33M

Maximum

Dec 2019

15.67M

Average

13.64M

Median

Mar 2023

Cash from Financing (TTM) Benchmarks